Brokerage Firm Rating on Stryker Corporation (SYK)

Stryker Corporation (SYK) : 14 brokerage houses believe that Stryker Corporation (SYK) is a Strong Buy at current levels. 2 Analyst considers the fundamentals to be worthy of a Buy recommendation. 5 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Stryker Corporation (SYK). Zacks Investment Research suggests a Hold with a rank of 3. 2 others believe that the stock has run up ahead of its fundamentals and advise a Strong Sell on the stock.The median of all the 23 Wall Street Analysts endorse the stock as a Buy with a rating of 1.85.

Stryker Corporation (SYK) : The consensus price target for Stryker Corporation (SYK) is $125.65 for the short term with a standard deviation of $11.36. The most optimist securities analyst among the 17 who monitor the stock believes that the stock can reach $138, however, the pessimist price target for the company is $88.


For the current week, the company shares have a recommendation consensus of Buy. Stryker Corporation (NYSE:SYK): The stock was completely flat for the day, closing at $115.53 on Thursday. The flat closing masks the intraday volatility in the stock. After opening at $115.52, the stock touched an intraday high of $116.05 and a low of $115.07. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $115.53. The total trading volume on Thursday was 782,267.

In a related news, Stryker Ronda E, director of Stryker Corp, unloaded 12,000 shares at an average price of $115.24 on August 3, 2016. The total amount of the transaction was worth $1,382,880, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.